Is Boston Scientific Corporation (BSX) Stock About to Get Hot Friday?

The market has been high on Boston Scientific Corporation (BSX) stock recently. BSX gets a Bullish score from InvestorsObserver Stock Sentiment Indicator.

Boston Scientific Corporation has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on BSX!

See Full BSX Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With BSX Stock Today?

Boston Scientific Corporation (BSX) stock has risen 0.52% while the S&P 500 has fallen -0.04% as of 3:37 PM on Friday, Jan 14. BSX has gained $0.23 from the previous closing price of $44.56 on volume of 5,669,216 shares. Over the past year the S&P 500 is up 22.25% while BSX has gained 24.21%. BSX earned $0.77 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 58.35.

More About Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales. Click Here to get the full Stock Report for Boston Scientific Corporation stock.